. "8" . "New drugs in type 2 diabetes mellitus therapy"@en . . . "I" . "Nov\u00E9 l\u00E9ky v terapii diabetes mellitus 2. typu"@cs . "6"^^ . . "Nov\u00E9 l\u00E9ky v terapii diabetes mellitus 2. typu"@cs . "C\u00EDlem v\u00FDvoje nov\u00E9 terapie pro l\u00E9\u010Dbu diabetu 2. typu je dosa\u017Een\u00ED v\u011Bt\u0161\u00ED bezpe\u010Dnosti a lep\u0161\u00ED \u00FA\u010Dinnosti. Nov\u011B byly registrov\u00E1ny lixisenatid, exenatid QW, dapagliflozin a inzulin degludec. Ve v\u00FDvoji jsou gliptiny s aplikac\u00ED 1kr\u00E1t t\u00FDdn\u011B a dal\u0161\u00ED l\u00E1tky."@cs . "C\u00EDlem v\u00FDvoje nov\u00E9 terapie pro l\u00E9\u010Dbu diabetu 2. typu je dosa\u017Een\u00ED v\u011Bt\u0161\u00ED bezpe\u010Dnosti a lep\u0161\u00ED \u00FA\u010Dinnosti. Nov\u011B byly registrov\u00E1ny lixisenatid, exenatid QW, dapagliflozin a inzulin degludec. Ve v\u00FDvoji jsou gliptiny s aplikac\u00ED 1kr\u00E1t t\u00FDdn\u011B a dal\u0161\u00ED l\u00E1tky." . . . "[882DF0E77CD1]" . "1"^^ . . . "59" . "The objective in developing a new type 2 diabetes therapy is to achieve greater safety and better efficacy. Newly registered drugs include lixisenatide, QW exenatide, dapagliflozin and insulin degludec. Once weekly gliptins and other substances are under development."@en . . "dapagliflozin; insulin degludec; lixisenatide; exenatide; gliptins; type 2 diabetes mellitus therapy"@en . "92221" . "New drugs in type 2 diabetes mellitus therapy"@en . . . "1"^^ . . . . "Vnit\u0159n\u00ED l\u00E9ka\u0159stv\u00ED" . . "http://www.prolekare.cz/vnitrni-lekarstvi-clanek/nove-leky-v-terapii-diabetes-mellitus-2-typu-41362" . "0042-773X" . . "CZ - \u010Cesk\u00E1 republika" . . "Kvapil, Milan" . . "RIV/00064203:_____/13:10195816!RIV14-MZ0-00064203" . "Nov\u00E9 l\u00E9ky v terapii diabetes mellitus 2. typu" . "Nov\u00E9 l\u00E9ky v terapii diabetes mellitus 2. typu" . "RIV/00064203:_____/13:10195816" .